CDC Updates Guidance on Meningitis Outbreak Linked to Compounded Medication

Why it matters locally: Alabama healthcare providers and patients who received compounded medications from New England Compounding Center should review their records and contact their healthcare providers if they received potentially affected products.

---

The Centers for Disease Control and Prevention (CDC) released updated guidance for healthcare providers and individuals concerning an ongoing nationwide outbreak of meningitis and stroke. The health issues are linked to contaminated medication produced by the New England Compounding Center (NECC), located in Framingham, Massachusetts. Health officials are tracing cases of infection back to specific NECC products. The CDC recommends that clinicians review their records to identify patients who may have received medications from the facility. Those patients should be contacted and evaluated for potential symptoms of meningitis or stroke. The updated guidance provides detailed information on identifying potentially contaminated products, recognizing symptoms of infection, and implementing appropriate treatment protocols. The CDC urges patients who received medication from NECC to seek immediate medical attention if they experience fever, headache, stiff neck, or other neurological symptoms.